Initial results from the first-ever international clinical trial of an experimental T-cell therapy for pediatric leukemia, led by Stephen Grupp, MD, PhD, have been published. It’s expected that the treatment will be filed for U.S. Food and Drug Administration approval in early 2017, and later in 2017 for European regulatory approval.
View additional CHOP Department of International Medicine Updates here.
World Trade Center of Greater Philadelphia News
News from the Children's Hospital of Philadelphia
Watch this space for WTCGP news, events, press, and more!